FORCHRONIC RECEIVES THE NEOTEC PROGRAM AWARD
Forchronic, a biotechnology company owned by the Autonomous University of Madrid and focused on the development of new precision nutritional and nutraceutical supplements, has RECEIVED THE AWARD OF THE NEOTEC PROGRAM OF THE YEAR 2020. The title of the project...
LAUNCH OF IMMUNELIPCHRONIC, FORCHRONIC’S NEW NUTRACEUTIC PRODUCT
Forchronic launches a new nutraceutical with a novel formulation to enhance and strengthen the immune system. Forchronic, a company owned by the Autonomous University of Madrid (UAM) and classified as a company based on the UAM’s knowledge, launches a new...
A formula with rosemary extract fights colon cancer
It has been developed by Forchronic and is being tested in patients with chemotherapy with positive results Forchronic has developed a new bioactive compound from supercritical rosemary extract high in terpenes that is showing positive results in chemotherapy...
